← SynDRA
LEVOBETAXOLOL
SynDRA canonical compound SYN0023510 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Primary target(s) | ADRB1 | ADRB2 |
| Mechanism of action | adrenergic receptor antagonist |
| Indication | glaucoma | intraocular pressure |
| Disease area | ophthalmology |
All known targets
Mechanisms of action (all sources)
- ADRB1 ANTAGONIST
- Beta-1 adrenergic receptor antagonist
- adrenergic receptor antagonist
Cross-references
Synonyms
- levobetaxolol hydrochloride
- (-)-Betaxolol
- betaxon
- levobetaxolol HCl
- Betaxolol, (s)-
- Levobetaxolol [INN]
- Betaxon (TN)
- (2S)-1-[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]-3-(propan-2-ylamino)propan-2-ol
- (2S)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(propan-2-ylamino)propan-2-ol
- (2s)-1-{4-[2-(cyclopropylmethoxy)ethyl]phenoxy}-3-(isopropylamino)propan-2-ol
- (S)-(-)-Betaxolol
- (S)-1-(isopropylamino)-3-[p-(cyclopropylmethoxyethyl)phenoxy]-2-propanol
- (S)-Betaxolol
- levobetaxololum
- CHEBI:59254
- RefChem:153195
- DTXCID50161832
- (S)-Betaxolol hydrochloride;AL-1577A
- UNII-75O9XHA4TU
- SCHEMBL23532
- LEVOBETAXOLOL [WHO-DD]
- GTPL8035
- orb1706016
- BDBM25752
- EBC-26564
- STK636241
- AKOS005568173
- NCGC00386278-01
- AC-30590
- HY-121166
- NS00098733
- T19682
- AB01566926_01
- Betaxolol Impurity 6; Levobetaxolol Hydrochloride
- EN300-18563034
- BRD-K43883465-003-01-5
- (S)-betaxolol
- (-)-betaxolol
Look up LEVOBETAXOLOL in the interactive SynDRA portal →